-transparent.png){kind=logo}
Chest imaging has a central role in the diagnosis and monitoring of sarcoidosis. For staging of pulmonary disease on chest radiograph, Scadding stages are still widely used. High-resolution CT (HRCT), however, is more accurate in visualizing the various manifestations of pulmonary sarcoidosis as well its complications. A generally accepted HRCT scoring system is lacking. Fluorodeoxyglucose F 18 positron emission tomography can visualize disease activity better than conventional makers in a significant proportion of patients. In patients with extensive changes on HRCT but no parenchymal fluorodeoxyglucose F 18 uptake, prudence with regard to initiation or intensification of immunosuppressive treatment is warranted.
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
May 1986,
Canadian family physician Medecin de famille canadien,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
October 2005,
Seminars in ultrasound, CT, and MR,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
December 2022,
Seminars in respiratory and critical care medicine,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
January 2005,
Journal de radiologie,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
May 2015,
Magnetic resonance imaging clinics of North America,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
October 2005,
Revue de pneumologie clinique,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
December 1990,
Current opinion in radiology,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
December 1991,
Current opinion in radiology,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
January 2015,
Radiologic technology,
Ruth G Keijsers, and
Marcel Veltkamp, and
Jan C Grutters
October 1992,
Current opinion in radiology,
